Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Matrix Metalloproteinase 9 | 23 | 2018 | 637 | 3.180 |
Why?
|
Matrix Metalloproteinase 2 | 30 | 2022 | 472 | 3.100 |
Why?
|
Neovascularization, Pathologic | 41 | 2022 | 2639 | 3.000 |
Why?
|
Matrix Metalloproteinases | 20 | 2019 | 391 | 2.900 |
Why?
|
Lipocalins | 11 | 2016 | 170 | 2.350 |
Why?
|
Acute-Phase Proteins | 10 | 2016 | 261 | 2.220 |
Why?
|
Metalloendopeptidases | 22 | 2011 | 395 | 1.970 |
Why?
|
Neovascularization, Physiologic | 14 | 2014 | 1352 | 1.500 |
Why?
|
Vascular Endothelial Growth Factor A | 19 | 2022 | 3504 | 1.330 |
Why?
|
Fibroblast Growth Factor 2 | 9 | 2022 | 600 | 1.280 |
Why?
|
Intercellular Adhesion Molecule-1 | 7 | 2023 | 1153 | 1.260 |
Why?
|
Mammary Neoplasms, Experimental | 3 | 2022 | 522 | 1.220 |
Why?
|
Extracellular Matrix | 14 | 2020 | 1734 | 1.210 |
Why?
|
Breast Neoplasms | 22 | 2020 | 20676 | 1.140 |
Why?
|
Liposomes | 8 | 2019 | 760 | 1.130 |
Why?
|
Angiogenesis Inhibitors | 14 | 2016 | 2037 | 1.100 |
Why?
|
ADAM Proteins | 6 | 2015 | 242 | 1.080 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 9 | 2022 | 68 | 1.060 |
Why?
|
Blood-Brain Barrier | 3 | 2020 | 1015 | 1.020 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2014 | 502 | 1.010 |
Why?
|
Cell Line, Tumor | 28 | 2023 | 16646 | 0.970 |
Why?
|
Pelvic Pain | 4 | 2021 | 269 | 0.960 |
Why?
|
Immunoconjugates | 2 | 2023 | 889 | 0.960 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 17 | 2009 | 99 | 0.960 |
Why?
|
Proto-Oncogene Proteins | 11 | 2016 | 4555 | 0.950 |
Why?
|
Cell Movement | 15 | 2019 | 5221 | 0.900 |
Why?
|
Urologic Diseases | 3 | 2020 | 239 | 0.830 |
Why?
|
Drug Delivery Systems | 5 | 2020 | 2220 | 0.820 |
Why?
|
Endocytosis | 3 | 2020 | 984 | 0.740 |
Why?
|
Transcytosis | 1 | 2019 | 44 | 0.700 |
Why?
|
Endothelial Cells | 13 | 2019 | 3435 | 0.700 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2020 | 194 | 0.690 |
Why?
|
Integrin alpha2 | 1 | 2019 | 40 | 0.690 |
Why?
|
Drug Carriers | 2 | 2019 | 693 | 0.670 |
Why?
|
Cattle | 18 | 2014 | 3913 | 0.650 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 7 | 2010 | 149 | 0.650 |
Why?
|
Flow Cytometry | 4 | 2019 | 5959 | 0.630 |
Why?
|
Progeria | 2 | 2018 | 184 | 0.630 |
Why?
|
Blood Vessels | 4 | 2012 | 1126 | 0.610 |
Why?
|
Nanoparticles | 3 | 2019 | 1906 | 0.600 |
Why?
|
Neoplasms | 15 | 2020 | 21507 | 0.600 |
Why?
|
Elastic Modulus | 1 | 2018 | 213 | 0.590 |
Why?
|
Time-Lapse Imaging | 1 | 2018 | 195 | 0.580 |
Why?
|
Holography | 1 | 2017 | 84 | 0.560 |
Why?
|
Up-Regulation | 9 | 2017 | 4205 | 0.550 |
Why?
|
Cell Proliferation | 20 | 2019 | 10455 | 0.540 |
Why?
|
Sports | 1 | 2021 | 685 | 0.520 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2019 | 705 | 0.510 |
Why?
|
Corpus Luteum | 5 | 2011 | 86 | 0.500 |
Why?
|
Neoplasm Metastasis | 9 | 2020 | 4832 | 0.500 |
Why?
|
Menopause | 1 | 2022 | 1613 | 0.490 |
Why?
|
Estrous Cycle | 4 | 2011 | 73 | 0.480 |
Why?
|
Ovarian Neoplasms | 4 | 2019 | 4815 | 0.480 |
Why?
|
Plasminogen | 5 | 2003 | 152 | 0.460 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 875 | 0.450 |
Why?
|
Chondrosarcoma | 4 | 2001 | 310 | 0.450 |
Why?
|
Cartilage | 5 | 1999 | 819 | 0.440 |
Why?
|
Membrane Proteins | 6 | 2015 | 7862 | 0.440 |
Why?
|
Blood Proteins | 1 | 2018 | 1122 | 0.440 |
Why?
|
Animals | 91 | 2022 | 168368 | 0.430 |
Why?
|
Astrocytes | 1 | 2020 | 1258 | 0.430 |
Why?
|
Adipocytes | 1 | 2019 | 1171 | 0.430 |
Why?
|
Endothelium, Vascular | 18 | 2007 | 4454 | 0.410 |
Why?
|
Athletic Injuries | 1 | 2021 | 1151 | 0.400 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2011 | 37 | 0.400 |
Why?
|
Osteosarcoma | 1 | 2017 | 884 | 0.390 |
Why?
|
Lymphangioleiomyomatosis | 3 | 2010 | 211 | 0.390 |
Why?
|
Dinoprost | 1 | 2011 | 140 | 0.390 |
Why?
|
Prostatic Hyperplasia | 1 | 2015 | 522 | 0.380 |
Why?
|
Polymers | 7 | 2007 | 1616 | 0.380 |
Why?
|
Mice, Nude | 8 | 2020 | 3692 | 0.380 |
Why?
|
Glioblastoma | 3 | 2019 | 3431 | 0.370 |
Why?
|
Brain Concussion | 1 | 2021 | 1317 | 0.370 |
Why?
|
Endothelium | 4 | 2019 | 776 | 0.370 |
Why?
|
Humans | 109 | 2023 | 739398 | 0.360 |
Why?
|
Piperidines | 1 | 2018 | 1597 | 0.350 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2011 | 1100 | 0.350 |
Why?
|
Carcinoma, Lewis Lung | 4 | 2003 | 115 | 0.350 |
Why?
|
Peptide Hydrolases | 3 | 2006 | 627 | 0.350 |
Why?
|
CA-125 Antigen | 1 | 2011 | 278 | 0.340 |
Why?
|
Endothelial Growth Factors | 5 | 2003 | 695 | 0.340 |
Why?
|
Stomach Neoplasms | 2 | 2017 | 1318 | 0.340 |
Why?
|
RNA, Small Interfering | 6 | 2019 | 3498 | 0.340 |
Why?
|
Uterine Diseases | 1 | 2010 | 135 | 0.330 |
Why?
|
Adenocarcinoma | 3 | 2015 | 6318 | 0.320 |
Why?
|
Estrogen Receptor alpha | 2 | 2009 | 575 | 0.320 |
Why?
|
Nanomedicine | 3 | 2020 | 305 | 0.320 |
Why?
|
Metalloproteases | 1 | 2008 | 62 | 0.320 |
Why?
|
Polyesters | 3 | 2005 | 367 | 0.320 |
Why?
|
Receptor, IGF Type 1 | 1 | 2010 | 390 | 0.320 |
Why?
|
Neoplasm Proteins | 3 | 2011 | 3694 | 0.310 |
Why?
|
Female | 61 | 2022 | 378853 | 0.310 |
Why?
|
Cells, Cultured | 22 | 2017 | 19220 | 0.300 |
Why?
|
Hypercholesterolemia | 1 | 2014 | 1143 | 0.300 |
Why?
|
Liver Regeneration | 2 | 2008 | 209 | 0.290 |
Why?
|
Pharynx | 2 | 2007 | 411 | 0.290 |
Why?
|
Matrix Metalloproteinase 1 | 6 | 2007 | 141 | 0.290 |
Why?
|
Glycoproteins | 8 | 2011 | 2259 | 0.290 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2019 | 5148 | 0.280 |
Why?
|
Mice | 37 | 2022 | 81002 | 0.280 |
Why?
|
Mouth | 2 | 2007 | 372 | 0.280 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2007 | 1213 | 0.280 |
Why?
|
Pyridines | 1 | 2018 | 2810 | 0.270 |
Why?
|
Urinary Tract | 2 | 2017 | 301 | 0.270 |
Why?
|
Oligopeptides | 1 | 2011 | 1179 | 0.270 |
Why?
|
Amino Acid Sequence | 16 | 2014 | 13816 | 0.270 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2019 | 8400 | 0.270 |
Why?
|
Tissue Engineering | 6 | 2010 | 1869 | 0.270 |
Why?
|
Protease Inhibitors | 6 | 2010 | 792 | 0.270 |
Why?
|
Antineoplastic Agents | 8 | 2020 | 13635 | 0.270 |
Why?
|
Vascular Endothelial Growth Factors | 5 | 2022 | 773 | 0.270 |
Why?
|
Doxorubicin | 3 | 2019 | 2218 | 0.270 |
Why?
|
Ureteral Obstruction | 2 | 2022 | 282 | 0.270 |
Why?
|
Polydioxanone | 1 | 2005 | 7 | 0.270 |
Why?
|
MicroRNAs | 2 | 2020 | 3712 | 0.270 |
Why?
|
Cell Division | 13 | 2005 | 4575 | 0.270 |
Why?
|
Molecular Sequence Data | 16 | 2014 | 18125 | 0.260 |
Why?
|
Sturge-Weber Syndrome | 2 | 2018 | 84 | 0.260 |
Why?
|
Neoplasm Transplantation | 4 | 2017 | 2084 | 0.250 |
Why?
|
Bioprosthesis | 2 | 2010 | 596 | 0.250 |
Why?
|
Doxycycline | 1 | 2006 | 327 | 0.250 |
Why?
|
Absorbable Implants | 5 | 2006 | 341 | 0.250 |
Why?
|
Craniopharyngioma | 1 | 2007 | 281 | 0.240 |
Why?
|
Blotting, Western | 11 | 2014 | 5181 | 0.240 |
Why?
|
Respiratory System | 1 | 2007 | 553 | 0.240 |
Why?
|
Microscopy, Atomic Force | 2 | 2018 | 248 | 0.240 |
Why?
|
Colonic Polyps | 1 | 2009 | 543 | 0.240 |
Why?
|
Mouth Mucosa | 1 | 2007 | 430 | 0.240 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2011 | 947 | 0.240 |
Why?
|
Molecular Weight | 6 | 2008 | 2257 | 0.240 |
Why?
|
Cloning, Molecular | 8 | 2005 | 4319 | 0.230 |
Why?
|
Estrogens | 1 | 2011 | 1561 | 0.230 |
Why?
|
Vascular Neoplasms | 1 | 2005 | 174 | 0.230 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1925 | 0.230 |
Why?
|
Proteomics | 4 | 2021 | 3584 | 0.230 |
Why?
|
DNA, Complementary | 6 | 2007 | 2049 | 0.230 |
Why?
|
Gelatin | 6 | 2007 | 226 | 0.220 |
Why?
|
Culture Media, Conditioned | 4 | 2020 | 532 | 0.220 |
Why?
|
Prostatic Neoplasms | 5 | 2015 | 10999 | 0.220 |
Why?
|
Down-Regulation | 4 | 2019 | 2999 | 0.220 |
Why?
|
Cell Culture Techniques | 3 | 2007 | 1662 | 0.220 |
Why?
|
RNA, Messenger | 14 | 2014 | 13002 | 0.210 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 1654 | 0.210 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2022 | 58 | 0.210 |
Why?
|
Peptide Fragments | 6 | 2003 | 5076 | 0.210 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2017 | 3863 | 0.210 |
Why?
|
Case-Control Studies | 8 | 2018 | 21694 | 0.210 |
Why?
|
Phosphoprotein Phosphatases | 2 | 2001 | 336 | 0.210 |
Why?
|
Hepatectomy | 2 | 2008 | 550 | 0.210 |
Why?
|
Endometriosis | 1 | 2010 | 832 | 0.210 |
Why?
|
ROC Curve | 3 | 2015 | 3526 | 0.200 |
Why?
|
Proteins | 7 | 2009 | 6082 | 0.200 |
Why?
|
Syndrome | 4 | 2021 | 3241 | 0.200 |
Why?
|
Mice, Obese | 1 | 2022 | 425 | 0.200 |
Why?
|
Repressor Proteins | 1 | 2012 | 3007 | 0.200 |
Why?
|
Molecular Targeted Therapy | 5 | 2019 | 2727 | 0.200 |
Why?
|
Collagenases | 4 | 1998 | 227 | 0.200 |
Why?
|
Gastrointestinal Tract | 1 | 2007 | 814 | 0.200 |
Why?
|
Hydronephrosis | 1 | 2022 | 260 | 0.200 |
Why?
|
Hydroxamic Acids | 4 | 2010 | 495 | 0.190 |
Why?
|
Antibodies | 2 | 2019 | 2450 | 0.190 |
Why?
|
Colon | 1 | 2009 | 1771 | 0.190 |
Why?
|
Esophagus | 1 | 2007 | 1017 | 0.190 |
Why?
|
Growth Substances | 2 | 1995 | 784 | 0.190 |
Why?
|
Gastrointestinal Diseases | 1 | 2009 | 1162 | 0.190 |
Why?
|
Lymphokines | 4 | 2003 | 950 | 0.190 |
Why?
|
Obesity | 2 | 2022 | 12643 | 0.180 |
Why?
|
Protein Array Analysis | 2 | 2015 | 411 | 0.180 |
Why?
|
Allantois | 4 | 2003 | 33 | 0.180 |
Why?
|
Extracellular Matrix Proteins | 2 | 2004 | 847 | 0.180 |
Why?
|
Wound Healing | 4 | 2014 | 2768 | 0.170 |
Why?
|
Base Sequence | 8 | 2012 | 12804 | 0.170 |
Why?
|
SNARE Proteins | 1 | 2019 | 89 | 0.170 |
Why?
|
Caveolins | 1 | 2019 | 104 | 0.170 |
Why?
|
Rats | 10 | 2007 | 24270 | 0.170 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2023 | 3562 | 0.170 |
Why?
|
Port-Wine Stain | 1 | 2018 | 33 | 0.170 |
Why?
|
Gene Expression Regulation | 5 | 2012 | 12049 | 0.170 |
Why?
|
Burkitt Lymphoma | 1 | 2001 | 329 | 0.170 |
Why?
|
Pituitary Neoplasms | 1 | 2007 | 1334 | 0.160 |
Why?
|
Rats, Sprague-Dawley | 7 | 2007 | 8299 | 0.160 |
Why?
|
Pneumonia, Bacterial | 1 | 2021 | 316 | 0.160 |
Why?
|
Filipin | 1 | 2018 | 13 | 0.160 |
Why?
|
Vascular Diseases | 2 | 2005 | 1152 | 0.160 |
Why?
|
Signal Transduction | 10 | 2019 | 23355 | 0.160 |
Why?
|
Prognosis | 9 | 2021 | 28901 | 0.160 |
Why?
|
Receptors, CXCR4 | 2 | 2014 | 726 | 0.160 |
Why?
|
Basement Membrane | 1 | 1999 | 356 | 0.160 |
Why?
|
Male | 42 | 2022 | 349022 | 0.160 |
Why?
|
Lipids | 2 | 2019 | 3307 | 0.160 |
Why?
|
Arachidonic Acid | 1 | 2019 | 438 | 0.160 |
Why?
|
Chlorpromazine | 1 | 2018 | 111 | 0.160 |
Why?
|
Angiostatins | 6 | 2012 | 67 | 0.160 |
Why?
|
Myoglobin | 1 | 2018 | 160 | 0.160 |
Why?
|
Interleukin-1alpha | 1 | 2018 | 83 | 0.150 |
Why?
|
Sheep | 8 | 2010 | 1434 | 0.150 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 247 | 0.150 |
Why?
|
Tissue Kallikreins | 1 | 2017 | 15 | 0.150 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 4743 | 0.150 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2008 | 2196 | 0.150 |
Why?
|
Interleukin-7 | 1 | 2018 | 142 | 0.150 |
Why?
|
Hydrazones | 1 | 2018 | 103 | 0.150 |
Why?
|
Collagen | 7 | 2006 | 2671 | 0.150 |
Why?
|
Lung Neoplasms | 8 | 2019 | 12985 | 0.150 |
Why?
|
Epithelial Cells | 2 | 2007 | 3671 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 4 | 2022 | 5502 | 0.150 |
Why?
|
beta 2-Microglobulin | 1 | 2018 | 316 | 0.150 |
Why?
|
Enzyme Inhibitors | 8 | 2018 | 3802 | 0.150 |
Why?
|
DNA Primers | 4 | 2012 | 2893 | 0.150 |
Why?
|
Mice, SCID | 2 | 2014 | 2716 | 0.150 |
Why?
|
Lamin Type A | 1 | 2018 | 189 | 0.150 |
Why?
|
Oncogene Proteins | 1 | 2001 | 750 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2015 | 9122 | 0.150 |
Why?
|
Tumor Cells, Cultured | 9 | 2015 | 6310 | 0.150 |
Why?
|
Longitudinal Studies | 4 | 2020 | 13880 | 0.140 |
Why?
|
Endosomes | 1 | 2019 | 527 | 0.140 |
Why?
|
Quinazolines | 2 | 2015 | 1356 | 0.140 |
Why?
|
Angiogenesis Inducing Agents | 2 | 2005 | 283 | 0.140 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 5 | 2004 | 1800 | 0.140 |
Why?
|
Isoenzymes | 2 | 2011 | 1720 | 0.140 |
Why?
|
Cell Line | 5 | 2019 | 15987 | 0.140 |
Why?
|
Matrix Metalloproteinase 3 | 2 | 2011 | 134 | 0.140 |
Why?
|
Ovary | 2 | 2019 | 982 | 0.140 |
Why?
|
Interleukin-13 | 1 | 2018 | 388 | 0.130 |
Why?
|
Capillaries | 5 | 2006 | 767 | 0.130 |
Why?
|
Aqueous Humor | 1 | 1996 | 163 | 0.130 |
Why?
|
Proteinuria | 1 | 2018 | 654 | 0.130 |
Why?
|
Kinetics | 4 | 2010 | 6475 | 0.130 |
Why?
|
Brain Neoplasms | 3 | 2019 | 8791 | 0.130 |
Why?
|
Chickens | 2 | 2015 | 864 | 0.130 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2018 | 343 | 0.130 |
Why?
|
Microcirculation | 4 | 2010 | 1285 | 0.130 |
Why?
|
Virus Internalization | 1 | 2019 | 499 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2015 | 545 | 0.130 |
Why?
|
Gelatinases | 5 | 2000 | 94 | 0.130 |
Why?
|
Proteome | 2 | 2015 | 1772 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 316 | 0.130 |
Why?
|
Hypertension, Pulmonary | 1 | 2005 | 1525 | 0.130 |
Why?
|
Semaphorins | 1 | 2015 | 101 | 0.130 |
Why?
|
Protein Transport | 2 | 2019 | 1991 | 0.120 |
Why?
|
Troponin I | 1 | 1999 | 616 | 0.120 |
Why?
|
Mice, Inbred C57BL | 10 | 2022 | 21863 | 0.120 |
Why?
|
Fibroblasts | 5 | 2011 | 4137 | 0.120 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2008 | 4400 | 0.120 |
Why?
|
Immunohistochemistry | 8 | 2012 | 11347 | 0.120 |
Why?
|
Dioxanes | 2 | 2005 | 37 | 0.120 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2012 | 628 | 0.120 |
Why?
|
Cholesterol, Dietary | 1 | 2014 | 232 | 0.120 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2012 | 851 | 0.120 |
Why?
|
Athletes | 1 | 2021 | 1086 | 0.120 |
Why?
|
Disease Models, Animal | 7 | 2019 | 18003 | 0.120 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2008 | 2397 | 0.120 |
Why?
|
Gene Expression | 6 | 2012 | 7788 | 0.120 |
Why?
|
Neuroglia | 1 | 2019 | 928 | 0.120 |
Why?
|
Cell Physiological Phenomena | 1 | 1995 | 154 | 0.110 |
Why?
|
Cisplatin | 1 | 2019 | 1617 | 0.110 |
Why?
|
Cardiovascular System | 1 | 2001 | 830 | 0.110 |
Why?
|
Cell Adhesion | 5 | 2005 | 3137 | 0.110 |
Why?
|
Materials Testing | 3 | 2006 | 864 | 0.110 |
Why?
|
Biocompatible Materials | 3 | 2005 | 1730 | 0.110 |
Why?
|
Growth Inhibitors | 2 | 1994 | 386 | 0.110 |
Why?
|
Neoplasm Invasiveness | 5 | 2012 | 3603 | 0.110 |
Why?
|
Azetidines | 1 | 2014 | 142 | 0.110 |
Why?
|
Child | 12 | 2022 | 77033 | 0.110 |
Why?
|
Cluster Analysis | 1 | 2020 | 2711 | 0.110 |
Why?
|
Lysophospholipids | 1 | 2015 | 330 | 0.110 |
Why?
|
Umbilical Veins | 2 | 2010 | 430 | 0.110 |
Why?
|
Stem Cells | 3 | 2015 | 3566 | 0.110 |
Why?
|
Neoplasm Staging | 3 | 2015 | 10961 | 0.110 |
Why?
|
Kidney | 5 | 2022 | 7144 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2015 | 10945 | 0.100 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6397 | 0.100 |
Why?
|
Disease Progression | 8 | 2019 | 13237 | 0.100 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1801 | 0.100 |
Why?
|
Apoptosis | 5 | 2014 | 9714 | 0.100 |
Why?
|
Phenanthrolines | 2 | 2004 | 59 | 0.100 |
Why?
|
Antibodies, Monoclonal | 3 | 2017 | 9259 | 0.100 |
Why?
|
Adult | 17 | 2021 | 213394 | 0.100 |
Why?
|
Tretinoin | 1 | 1994 | 513 | 0.100 |
Why?
|
Gene Knockout Techniques | 1 | 2014 | 803 | 0.100 |
Why?
|
Urinary Bladder | 1 | 1997 | 1153 | 0.100 |
Why?
|
Vitamin A | 1 | 1994 | 613 | 0.100 |
Why?
|
Cell-Derived Microparticles | 1 | 2012 | 168 | 0.090 |
Why?
|
Open Reading Frames | 3 | 2001 | 810 | 0.090 |
Why?
|
Enzyme Assays | 1 | 2011 | 111 | 0.090 |
Why?
|
Child, Preschool | 7 | 2022 | 40802 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2507 | 0.090 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7136 | 0.090 |
Why?
|
Intercellular Signaling Peptides and Proteins | 5 | 2011 | 1675 | 0.090 |
Why?
|
Fetal Diseases | 2 | 2010 | 903 | 0.090 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2010 | 66 | 0.090 |
Why?
|
Protein Structure, Tertiary | 2 | 2010 | 3848 | 0.090 |
Why?
|
Chick Embryo | 6 | 2003 | 978 | 0.090 |
Why?
|
Transcription Factors | 4 | 2009 | 12120 | 0.090 |
Why?
|
Fibrosarcoma | 2 | 2003 | 348 | 0.090 |
Why?
|
Substrate Specificity | 3 | 2007 | 1798 | 0.090 |
Why?
|
Genetic Vectors | 1 | 2019 | 3419 | 0.090 |
Why?
|
Pregnancy, Animal | 1 | 2010 | 134 | 0.090 |
Why?
|
Blood Platelets | 1 | 2020 | 2506 | 0.090 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2011 | 310 | 0.090 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 364 | 0.090 |
Why?
|
Collagen Type IV | 2 | 2012 | 136 | 0.090 |
Why?
|
Protein Binding | 2 | 2012 | 9375 | 0.090 |
Why?
|
Recombinant Proteins | 4 | 2015 | 6610 | 0.090 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2011 | 403 | 0.090 |
Why?
|
Glaucoma | 1 | 2018 | 1140 | 0.080 |
Why?
|
Venules | 1 | 2009 | 163 | 0.080 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2009 | 191 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2003 | 648 | 0.080 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 5863 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2217 | 0.080 |
Why?
|
Neoplasms, Experimental | 4 | 2002 | 1280 | 0.080 |
Why?
|
Cell Count | 3 | 2007 | 1833 | 0.080 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2010 | 664 | 0.080 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2012 | 689 | 0.080 |
Why?
|
Protein Biosynthesis | 1 | 1996 | 2131 | 0.080 |
Why?
|
Diffusion Tensor Imaging | 1 | 2018 | 2301 | 0.080 |
Why?
|
Cathepsins | 1 | 2009 | 237 | 0.080 |
Why?
|
Enzyme Activation | 5 | 2005 | 3701 | 0.080 |
Why?
|
Tibia | 1 | 2014 | 1072 | 0.080 |
Why?
|
Cell Lineage | 1 | 2017 | 2486 | 0.080 |
Why?
|
Young Adult | 7 | 2021 | 56255 | 0.080 |
Why?
|
Liver | 2 | 2018 | 7449 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2001 | 5012 | 0.080 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2003 | 2833 | 0.080 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2015 | 1214 | 0.080 |
Why?
|
Aged | 12 | 2017 | 162698 | 0.080 |
Why?
|
Prospective Studies | 4 | 2022 | 53037 | 0.080 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 1994 | 0.080 |
Why?
|
Densitometry | 2 | 2004 | 156 | 0.080 |
Why?
|
Cross-Linking Reagents | 1 | 2010 | 696 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3508 | 0.070 |
Why?
|
Area Under Curve | 1 | 2011 | 1655 | 0.070 |
Why?
|
Adolescent | 8 | 2018 | 85405 | 0.070 |
Why?
|
Middle Aged | 13 | 2018 | 212863 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2015 | 1380 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 894 | 0.070 |
Why?
|
Dimerization | 1 | 2008 | 892 | 0.070 |
Why?
|
Reference Values | 2 | 2009 | 4983 | 0.070 |
Why?
|
Melanocytes | 2 | 2017 | 514 | 0.070 |
Why?
|
Pericardium | 1 | 2011 | 665 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2001 | 5830 | 0.070 |
Why?
|
Transcriptional Activation | 1 | 2012 | 1783 | 0.070 |
Why?
|
Tamoxifen | 1 | 2011 | 978 | 0.070 |
Why?
|
Disintegrins | 1 | 2006 | 24 | 0.070 |
Why?
|
Plastics | 1 | 2007 | 122 | 0.070 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2007 | 426 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3752 | 0.070 |
Why?
|
Immunoprecipitation | 1 | 2008 | 903 | 0.070 |
Why?
|
Phenotype | 7 | 2010 | 16301 | 0.070 |
Why?
|
Biodegradation, Environmental | 2 | 2003 | 221 | 0.070 |
Why?
|
Hemangioma | 2 | 2015 | 738 | 0.070 |
Why?
|
Peptides | 2 | 2004 | 4395 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2011 | 1285 | 0.070 |
Why?
|
Mesoderm | 1 | 2009 | 683 | 0.070 |
Why?
|
Bone Marrow | 2 | 2020 | 2933 | 0.070 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2007 | 956 | 0.070 |
Why?
|
Chorion | 3 | 2003 | 117 | 0.070 |
Why?
|
Rare Diseases | 1 | 2010 | 553 | 0.070 |
Why?
|
Myeloid Cells | 1 | 2010 | 799 | 0.060 |
Why?
|
Keratins | 1 | 2007 | 516 | 0.060 |
Why?
|
Prolactin | 1 | 2007 | 668 | 0.060 |
Why?
|
Cholesterol | 1 | 2014 | 2900 | 0.060 |
Why?
|
Chromatography, Affinity | 2 | 2004 | 550 | 0.060 |
Why?
|
Epidermal Growth Factor | 2 | 1998 | 706 | 0.060 |
Why?
|
Cardiac Output, Low | 1 | 2005 | 193 | 0.060 |
Why?
|
Sclerotherapy | 1 | 2006 | 174 | 0.060 |
Why?
|
PPAR alpha | 1 | 2006 | 196 | 0.060 |
Why?
|
Logistic Models | 2 | 2011 | 13402 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4391 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2008 | 14740 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2009 | 11460 | 0.060 |
Why?
|
Electrophoresis | 1 | 2004 | 240 | 0.060 |
Why?
|
Surface Properties | 1 | 2007 | 1181 | 0.060 |
Why?
|
Sepharose | 1 | 2004 | 108 | 0.060 |
Why?
|
Immunoblotting | 2 | 2005 | 1683 | 0.060 |
Why?
|
Chromatography, Ion Exchange | 1 | 2004 | 305 | 0.060 |
Why?
|
Ultracentrifugation | 1 | 2004 | 182 | 0.060 |
Why?
|
Edetic Acid | 1 | 2004 | 277 | 0.060 |
Why?
|
Cyclohexanes | 1 | 2004 | 153 | 0.060 |
Why?
|
Caseins | 1 | 2004 | 103 | 0.060 |
Why?
|
Ligands | 2 | 2009 | 3311 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9622 | 0.060 |
Why?
|
Lymphatic Abnormalities | 1 | 2005 | 133 | 0.060 |
Why?
|
Binding Sites | 1 | 2012 | 6113 | 0.060 |
Why?
|
Sesquiterpenes | 1 | 2004 | 176 | 0.060 |
Why?
|
Skin Absorption | 1 | 2003 | 93 | 0.060 |
Why?
|
Leg Ulcer | 1 | 2003 | 69 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3615 | 0.060 |
Why?
|
Fibronectins | 2 | 2004 | 723 | 0.060 |
Why?
|
Awards and Prizes | 1 | 2008 | 375 | 0.060 |
Why?
|
Mucous Membrane | 1 | 2007 | 667 | 0.060 |
Why?
|
Lymphangiogenesis | 1 | 2004 | 170 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1025 | 0.060 |
Why?
|
Infusion Pumps, Implantable | 1 | 2003 | 156 | 0.060 |
Why?
|
Epilepsy | 1 | 2018 | 3289 | 0.060 |
Why?
|
Chelating Agents | 1 | 2004 | 380 | 0.060 |
Why?
|
Catalysis | 1 | 2004 | 759 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2183 | 0.050 |
Why?
|
Elastin | 2 | 2001 | 305 | 0.050 |
Why?
|
Sequence Analysis, DNA | 2 | 2005 | 4791 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 502 | 0.050 |
Why?
|
Endometrial Neoplasms | 1 | 2012 | 1351 | 0.050 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2011 | 1497 | 0.050 |
Why?
|
Inhibitory Concentration 50 | 1 | 2003 | 464 | 0.050 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2006 | 311 | 0.050 |
Why?
|
Databases as Topic | 1 | 2004 | 473 | 0.050 |
Why?
|
COS Cells | 1 | 2004 | 1159 | 0.050 |
Why?
|
Tandem Mass Spectrometry | 1 | 2008 | 1156 | 0.050 |
Why?
|
Myocytes, Cardiac | 1 | 2011 | 1625 | 0.050 |
Why?
|
Gene Silencing | 1 | 2009 | 1537 | 0.050 |
Why?
|
MAP Kinase Signaling System | 2 | 2015 | 1522 | 0.050 |
Why?
|
Myocardium | 2 | 2011 | 4788 | 0.050 |
Why?
|
Carcinoma in Situ | 1 | 2008 | 799 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2015 | 4463 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 2 | 2010 | 2845 | 0.050 |
Why?
|
Calciphylaxis | 1 | 2003 | 122 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2014 | 1939 | 0.050 |
Why?
|
Chorioallantoic Membrane | 2 | 2015 | 47 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2008 | 15036 | 0.050 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2007 | 838 | 0.050 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2002 | 94 | 0.050 |
Why?
|
History, 21st Century | 1 | 2008 | 1534 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3510 | 0.050 |
Why?
|
Kidney Pelvis | 1 | 2022 | 174 | 0.050 |
Why?
|
Administration, Cutaneous | 1 | 2003 | 708 | 0.050 |
Why?
|
Collagen Type I | 1 | 2004 | 577 | 0.050 |
Why?
|
Hydroxyproline | 1 | 2001 | 114 | 0.050 |
Why?
|
Enzyme Stability | 1 | 2001 | 210 | 0.050 |
Why?
|
Zebrafish | 1 | 2012 | 2980 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12948 | 0.050 |
Why?
|
Time Factors | 7 | 2015 | 40050 | 0.050 |
Why?
|
Dietary Carbohydrates | 1 | 2006 | 904 | 0.050 |
Why?
|
3T3 Cells | 2 | 2002 | 1103 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 2 | 2007 | 1991 | 0.050 |
Why?
|
Gene Expression Profiling | 3 | 2009 | 9387 | 0.050 |
Why?
|
Precancerous Conditions | 1 | 2008 | 966 | 0.050 |
Why?
|
Actins | 2 | 2007 | 2112 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12237 | 0.050 |
Why?
|
Lymphatic Metastasis | 1 | 2009 | 2897 | 0.050 |
Why?
|
Heart Valve Prosthesis | 1 | 2010 | 1479 | 0.050 |
Why?
|
Polymerase Chain Reaction | 3 | 2009 | 6174 | 0.050 |
Why?
|
Iron | 1 | 2009 | 1776 | 0.050 |
Why?
|
Proteoglycans | 2 | 2001 | 835 | 0.050 |
Why?
|
Microspheres | 1 | 2003 | 778 | 0.050 |
Why?
|
Coated Materials, Biocompatible | 1 | 2003 | 315 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2001 | 829 | 0.050 |
Why?
|
Hydrogels | 1 | 2006 | 720 | 0.050 |
Why?
|
Heparin | 2 | 1998 | 1637 | 0.050 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2001 | 198 | 0.050 |
Why?
|
Gene Library | 1 | 2003 | 1077 | 0.050 |
Why?
|
Infant | 5 | 2018 | 34923 | 0.050 |
Why?
|
Fatty Liver | 1 | 2006 | 714 | 0.050 |
Why?
|
RNA, Neoplasm | 1 | 2003 | 761 | 0.050 |
Why?
|
Cranial Nerve Injuries | 1 | 2000 | 25 | 0.050 |
Why?
|
Protective Agents | 1 | 2001 | 156 | 0.050 |
Why?
|
Zinc | 1 | 2004 | 683 | 0.050 |
Why?
|
United States | 3 | 2021 | 69573 | 0.050 |
Why?
|
Culture Techniques | 1 | 2000 | 557 | 0.050 |
Why?
|
Lingual Nerve | 1 | 2000 | 33 | 0.050 |
Why?
|
Interleukin-6 | 2 | 2008 | 3194 | 0.040 |
Why?
|
Drug Monitoring | 1 | 2006 | 961 | 0.040 |
Why?
|
Taste Disorders | 1 | 2000 | 41 | 0.040 |
Why?
|
History, 20th Century | 1 | 2008 | 2742 | 0.040 |
Why?
|
Cell Survival | 2 | 2012 | 5877 | 0.040 |
Why?
|
Polyglactin 910 | 1 | 1999 | 58 | 0.040 |
Why?
|
Pancreatic Elastase | 1 | 1999 | 135 | 0.040 |
Why?
|
5' Untranslated Regions | 1 | 2001 | 250 | 0.040 |
Why?
|
Bucladesine | 1 | 1999 | 121 | 0.040 |
Why?
|
Fibrosis | 3 | 2010 | 2024 | 0.040 |
Why?
|
Mechanotransduction, Cellular | 1 | 2004 | 538 | 0.040 |
Why?
|
Postoperative Period | 1 | 2004 | 1835 | 0.040 |
Why?
|
Urethral Obstruction | 1 | 1999 | 55 | 0.040 |
Why?
|
Thiazolidinediones | 1 | 2002 | 474 | 0.040 |
Why?
|
Plasmids | 1 | 2004 | 2307 | 0.040 |
Why?
|
Hemangioendothelioma | 1 | 1999 | 121 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2008 | 6370 | 0.040 |
Why?
|
Homeostasis | 2 | 2011 | 3348 | 0.040 |
Why?
|
Membranes, Artificial | 1 | 2000 | 377 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2140 | 0.040 |
Why?
|
Sequence Analysis | 1 | 1999 | 257 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2001 | 508 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 727 | 0.040 |
Why?
|
Taste | 1 | 2000 | 175 | 0.040 |
Why?
|
Transplantation, Autologous | 2 | 2000 | 2119 | 0.040 |
Why?
|
Hemangiosarcoma | 1 | 2000 | 228 | 0.040 |
Why?
|
Sex Factors | 2 | 2018 | 10398 | 0.040 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 1998 | 131 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 862 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 2000 | 432 | 0.040 |
Why?
|
Rabbits | 3 | 2012 | 4882 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4743 | 0.040 |
Why?
|
Protein Engineering | 1 | 2001 | 543 | 0.040 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 1997 | 79 | 0.040 |
Why?
|
Transfection | 1 | 2005 | 5884 | 0.040 |
Why?
|
Oncogene Protein p21(ras) | 1 | 1997 | 83 | 0.040 |
Why?
|
Endostatins | 2 | 2012 | 174 | 0.040 |
Why?
|
Cornea | 3 | 2004 | 1488 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1999 | 489 | 0.040 |
Why?
|
Aorta, Abdominal | 1 | 1999 | 645 | 0.040 |
Why?
|
Adrenal Cortex | 2 | 2003 | 139 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6871 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2017 | 57650 | 0.040 |
Why?
|
Estrus | 1 | 1996 | 83 | 0.040 |
Why?
|
Fetus | 2 | 2010 | 1877 | 0.030 |
Why?
|
Megakaryocytes | 1 | 2020 | 542 | 0.030 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1997 | 257 | 0.030 |
Why?
|
Extracellular Space | 1 | 1998 | 594 | 0.030 |
Why?
|
Colitis, Ulcerative | 1 | 2008 | 1899 | 0.030 |
Why?
|
Stroke | 1 | 2018 | 9898 | 0.030 |
Why?
|
Pilot Projects | 1 | 2009 | 8275 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2001 | 1725 | 0.030 |
Why?
|
Leukemia Virus, Murine | 1 | 2016 | 116 | 0.030 |
Why?
|
Blood Vessel Prosthesis | 1 | 2000 | 932 | 0.030 |
Why?
|
Receptors, Cannabinoid | 1 | 2015 | 44 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2003 | 2936 | 0.030 |
Why?
|
Neoplasms, Vascular Tissue | 1 | 2015 | 35 | 0.030 |
Why?
|
Crohn Disease | 1 | 2008 | 2299 | 0.030 |
Why?
|
Thiazoles | 1 | 2002 | 1488 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2003 | 1066 | 0.030 |
Why?
|
Sarcoma 180 | 1 | 1994 | 6 | 0.030 |
Why?
|
Carotid Arteries | 1 | 1999 | 952 | 0.030 |
Why?
|
Biological Availability | 1 | 2015 | 390 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2015 | 38942 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2003 | 2381 | 0.030 |
Why?
|
Polysaccharide-Lyases | 1 | 1994 | 48 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2005 | 3097 | 0.030 |
Why?
|
Sarcoma, Experimental | 1 | 1994 | 128 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2002 | 2084 | 0.030 |
Why?
|
Women's Health | 1 | 2004 | 2029 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2006 | 2394 | 0.030 |
Why?
|
Brain Stem | 1 | 2018 | 849 | 0.030 |
Why?
|
Mutation | 1 | 2018 | 29658 | 0.030 |
Why?
|
Protein Kinase C | 1 | 1998 | 1223 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1998 | 2256 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2003 | 2149 | 0.030 |
Why?
|
Ferric Compounds | 1 | 2014 | 375 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2003 | 2948 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 625 | 0.030 |
Why?
|
Genomics | 1 | 2008 | 5652 | 0.030 |
Why?
|
Aging | 1 | 2011 | 8613 | 0.030 |
Why?
|
Conserved Sequence | 1 | 1996 | 1203 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2001 | 2965 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 691 | 0.030 |
Why?
|
Heart Rate | 1 | 2003 | 4095 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2000 | 1909 | 0.030 |
Why?
|
Age of Onset | 1 | 2018 | 3263 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1778 | 0.030 |
Why?
|
Creatinine | 2 | 2010 | 1903 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15511 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 2017 | 1182 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2003 | 2530 | 0.020 |
Why?
|
Scapula | 1 | 1992 | 162 | 0.020 |
Why?
|
Hydrocortisone | 1 | 1999 | 1809 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 952 | 0.020 |
Why?
|
Risk Assessment | 2 | 2013 | 23294 | 0.020 |
Why?
|
Organ Specificity | 1 | 1996 | 2004 | 0.020 |
Why?
|
Oncogenes | 1 | 1997 | 1264 | 0.020 |
Why?
|
Caveolin 1 | 1 | 2012 | 264 | 0.020 |
Why?
|
Swine | 2 | 2003 | 5901 | 0.020 |
Why?
|
Chronic Disease | 2 | 2021 | 9133 | 0.020 |
Why?
|
Matrix Metalloproteinases, Secreted | 1 | 2010 | 14 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1991 | 1088 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2010 | 2102 | 0.020 |
Why?
|
Incidence | 1 | 2008 | 20913 | 0.020 |
Why?
|
Cystatin A | 1 | 2009 | 5 | 0.020 |
Why?
|
Cystatin B | 1 | 2009 | 11 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1999 | 2100 | 0.020 |
Why?
|
Drug Synergism | 1 | 2014 | 1792 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 2503 | 0.020 |
Why?
|
Heart Injuries | 1 | 2011 | 210 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2014 | 2558 | 0.020 |
Why?
|
Pressure | 1 | 2012 | 1201 | 0.020 |
Why?
|
Neutrophils | 1 | 2001 | 3698 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2373 | 0.020 |
Why?
|
Age Factors | 1 | 2005 | 18349 | 0.020 |
Why?
|
In Situ Hybridization | 2 | 2003 | 1934 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1995 | 1504 | 0.020 |
Why?
|
Hot Temperature | 1 | 1994 | 1358 | 0.020 |
Why?
|
Autoantigens | 1 | 2012 | 891 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2008 | 25470 | 0.020 |
Why?
|
Bone Morphogenetic Protein 1 | 1 | 2007 | 9 | 0.020 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2009 | 200 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 3909 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 1991 | 962 | 0.020 |
Why?
|
Models, Biological | 3 | 2012 | 9609 | 0.020 |
Why?
|
Biological Assay | 1 | 1990 | 653 | 0.020 |
Why?
|
Animals, Newborn | 1 | 1992 | 2732 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 2010 | 925 | 0.020 |
Why?
|
Hepatocyte Growth Factor | 1 | 2008 | 270 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2008 | 527 | 0.020 |
Why?
|
Matrix Metalloproteinase 14 | 1 | 2005 | 60 | 0.020 |
Why?
|
Peptide Library | 1 | 2007 | 362 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 480 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2008 | 358 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 489 | 0.020 |
Why?
|
Luciferases | 1 | 2007 | 734 | 0.020 |
Why?
|
Ventricular Pressure | 1 | 2005 | 199 | 0.020 |
Why?
|
Calcium | 1 | 1998 | 5742 | 0.020 |
Why?
|
Polystyrenes | 1 | 2005 | 112 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2004 | 63 | 0.020 |
Why?
|
Growth Hormone | 1 | 2007 | 703 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 1990 | 879 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2004 | 127 | 0.010 |
Why?
|
Dipeptides | 1 | 2005 | 409 | 0.010 |
Why?
|
Transducers | 1 | 2004 | 252 | 0.010 |
Why?
|
Neuropeptides | 1 | 2009 | 942 | 0.010 |
Why?
|
Periodicity | 1 | 2004 | 365 | 0.010 |
Why?
|
Melanoma | 2 | 2017 | 5446 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2007 | 1549 | 0.010 |
Why?
|
Physical Stimulation | 1 | 2004 | 526 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 2010 | 1227 | 0.010 |
Why?
|
Injections | 1 | 2006 | 837 | 0.010 |
Why?
|
Elasticity | 1 | 2004 | 656 | 0.010 |
Why?
|
Organ Size | 1 | 2008 | 2247 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1122 | 0.010 |
Why?
|
Corneal Neovascularization | 1 | 2004 | 188 | 0.010 |
Why?
|
Homozygote | 1 | 2007 | 1788 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1793 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2003 | 286 | 0.010 |
Why?
|
Protein Kinases | 1 | 2009 | 1637 | 0.010 |
Why?
|
Ultrasonography, Prenatal | 1 | 2010 | 1689 | 0.010 |
Why?
|
Prostate | 1 | 2010 | 1743 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8605 | 0.010 |
Why?
|
Sirolimus | 1 | 2009 | 1559 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2004 | 1837 | 0.010 |
Why?
|
Biomedical Research | 1 | 2017 | 3301 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1998 | 4189 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6516 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 2003 | 316 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2007 | 1698 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5959 | 0.010 |
Why?
|
Agar | 1 | 2000 | 56 | 0.010 |
Why?
|
Receptors, Growth Factor | 1 | 2002 | 334 | 0.010 |
Why?
|
Chromones | 1 | 2000 | 155 | 0.010 |
Why?
|
Echocardiography | 2 | 2005 | 5098 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3493 | 0.010 |
Why?
|
Enzyme Precursors | 1 | 2000 | 176 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10534 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2002 | 1583 | 0.010 |
Why?
|
Collagen Type XVIII | 1 | 1999 | 56 | 0.010 |
Why?
|
Larynx | 1 | 2005 | 486 | 0.010 |
Why?
|
Porosity | 1 | 2000 | 362 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2004 | 1682 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6361 | 0.010 |
Why?
|
Trachea | 1 | 2005 | 1074 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2002 | 551 | 0.010 |
Why?
|
Cell Size | 1 | 2000 | 641 | 0.010 |
Why?
|
Ventricular Remodeling | 1 | 2005 | 1222 | 0.010 |
Why?
|
Pregnancy | 2 | 2010 | 29002 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2002 | 2345 | 0.010 |
Why?
|
Skin | 1 | 2011 | 4324 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2000 | 883 | 0.010 |
Why?
|
Pulmonary Circulation | 1 | 2000 | 740 | 0.010 |
Why?
|
Biotechnology | 1 | 1999 | 277 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2015 | 35326 | 0.010 |
Why?
|
Flavonoids | 1 | 2000 | 443 | 0.010 |
Why?
|
Cell Transplantation | 1 | 1999 | 478 | 0.010 |
Why?
|
Glycosaminoglycans | 1 | 2000 | 624 | 0.010 |
Why?
|
Morpholines | 1 | 2000 | 562 | 0.010 |
Why?
|
Heart | 1 | 2011 | 4466 | 0.010 |
Why?
|
Connective Tissue | 1 | 1999 | 411 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 1993 | 3689 | 0.010 |
Why?
|
Lung | 1 | 1996 | 9782 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1998 | 821 | 0.010 |
Why?
|
Vascular Patency | 1 | 1999 | 888 | 0.010 |
Why?
|
Body Weight | 1 | 2008 | 4660 | 0.010 |
Why?
|
H-2 Antigens | 1 | 1997 | 365 | 0.010 |
Why?
|
Simian virus 40 | 1 | 1997 | 295 | 0.010 |
Why?
|
Veins | 1 | 2000 | 767 | 0.010 |
Why?
|
Graft Occlusion, Vascular | 1 | 1999 | 551 | 0.010 |
Why?
|
Phosphorylation | 1 | 2007 | 8416 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1996 | 918 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1997 | 897 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 1999 | 929 | 0.010 |
Why?
|
Androstadienes | 1 | 1997 | 340 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 1998 | 864 | 0.010 |
Why?
|
Heparin Lyase | 1 | 1994 | 37 | 0.010 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 433 | 0.010 |
Why?
|
Cell Hypoxia | 1 | 1997 | 676 | 0.010 |
Why?
|
Microsurgery | 1 | 2000 | 793 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2002 | 1659 | 0.010 |
Why?
|
Biopsy | 1 | 2006 | 6722 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14558 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1994 | 672 | 0.010 |
Why?
|
Radiotherapy | 1 | 2001 | 1526 | 0.010 |
Why?
|
Protein Precursors | 1 | 1998 | 1154 | 0.010 |
Why?
|
Cytoplasm | 1 | 1998 | 1536 | 0.010 |
Why?
|
Histones | 1 | 2003 | 2591 | 0.010 |
Why?
|
Weight Loss | 1 | 2003 | 2589 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2011 | 62693 | 0.010 |
Why?
|
Cell Cycle | 1 | 2000 | 2960 | 0.010 |
Why?
|
Progesterone | 1 | 1996 | 772 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1994 | 1580 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2011 | 11668 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1998 | 3770 | 0.010 |
Why?
|
Cell Membrane | 1 | 1997 | 3747 | 0.000 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 1997 | 2933 | 0.000 |
Why?
|
DNA | 1 | 1999 | 7275 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2000 | 76631 | 0.000 |
Why?
|